(Source: Fitch Inc) 23 Nov 2015 5:20 PM EST Fitch Ratings-Chicago-23 November 2015: Fitch Ratings has placed Pfizer's long-term credit ratings on Negative Watch. The rating action follows Pfizer, Inc.'s (PFE) announcement that it will merge with Allergan plc (AGN) for roughly $143 billion in stock and an estimated $32 billion Allergan debt outstanding at the time of the transaction. Pfizer will also offer up to $12 billion cash for current Pfizer shares, assuming existing shareholders tender a minimum of $6 billion for cash settlement. The company expects the transaction to close in the second half of 2016. In addition Fitch has affirmed Pfizer's Short-term Issuer-Default Ratings at 'F1' and...
↧